


Seidl et al. 58F Metastatic Melanoma
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1 The MERIT StudySeidl et al.58-year-old woman with metastatic melanoma These are representative images from reference studies; individual results may vary.Reference: 1. Seidl Z,...
Rowley et al. 55F Glioblastoma with Recurrent Disease
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 The ENHANCE Study Rowley et al. 55-year-old woman with glioblastoma with recurrent disease These are representative images...
Maravilla et al. 51F Metastatic Lung Cancer
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1 Maravilla et al.51-year-old woman with metastatic lung cancer These are representative images from reference studies;...
Recent Comments